NC
Neurocompute
AI-powered research intelligence
 Partner With Us →
Live corpus
Active intelligence prompt Pediatric cancer: surface high-value therapeutic signals across pediatric oncology literature.
PEDIATRIC CANCER RESEARCH INTELLIGENCE

Finding therapies hidden in 40,351 pediatric cancer papers.

Neurocompute scores pediatric oncology literature, surfaces overlooked therapeutic signals, and turns fragmented childhood cancer research into a living discovery terminal.

Explore Platform → See latest papers
40,351 Papers indexed
1,440 Papers AI scored
40,351 Ranked papers
100.0% Coverage
PATIENT-FRIENDLY SUMMARY

CHIP-AML22: a complex clinical trial in de novo pediatric AML patients, including a gemtuzumab ozogamicin randomization and targeted therapy with quizartinib in eligible subgroups, within the NOPHO-DB-SHIP consortium.

For education only—not personal medical advice.
LIVE PEDIATRIC ONCOLOGY INTELLIGENCE
↑ Therapeutic signals emerging ↑ New pediatric cancer papers ingested ↑ Cross-paper convergence detected ↑ Human relevance scores updating ↑ Overlooked treatment paths surfacing
TOP PEDIATRIC CANCER SIGNALS

Ranked Discovery Journal Articles

View all discoveries →
LATEST PEDIATRIC CANCER PAPERS

Database feed

Last ingest 2026-11-12 10:15 AM
1 Interventions to reduce paediatric cancer treatment abandonment in low-income and middle-income countries: a systematic review and meta-analysis. The Lancet. Global health — Nov 12, 2026 2 Paediatric cancer treatment abandonment: multifaceted solutions required. The Lancet. Global health — Nov 12, 2026 3 Conjunctival inflammatory myofibroblastic tumour in infancy: diagnostic challenges and sequential histopathological evolution. BMJ case reports — Nov 12, 2026 4 Genome-wide association study meta-analysis identifies susceptibility loci informing Ewing sarcoma etiology and potential mechanisms of risk. Cell genomics — Nov 12, 2026 5 Getting on the "same page": Couples' experiences communicating about hereditary cancer risk and family building decisions. Journal of psychosocial oncology — Nov 12, 2026 6 SPROUT Guidelines for Molecular Profiling for Children with Solid Tumors: A Consensus Recommendation from the American Association for Cancer Research. Clinical cancer research : an official journal of the American Association for Cancer Research — Nov 12, 2026 7 Association of medical play therapy with psychological resilience during chemotherapy in children with malignant lymphoma: a propensity score-weighted retrospective cohort study. Psychology, health & medicine — Nov 12, 2026 8 Expression patterns of hypoxia signaling pathway genes and their association with clinical biochemical parameters in acute myeloid leukemia patients of Assam: A case control study. Molecular biology reports — Nov 12, 2026
PEDIATRIC CANCER RESEARCH TERMINAL

All ranked pediatric cancer papers

40351 results
D
Incidence, and maternal and neonatal outcomes following pregnancy-associated colorectal cancer: A population-based linked data study.
PMID 39530257 Published: 2024-11-12 Ingested: 2026-08-02 12:02 AM The journal of obstetrics and gynaecology research
AI -
Standard 39.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 39.5/100. Study design: 25.0; human relevance: 35.0; therapeutic relevance: 20.0; sample size: 20.0; recency: 90.0; abstract quality: 100.0.

D
Human papillomavirus-associated cancers, precancers, and genital warts in Denmark, 2000-2022 - Current burden of disease and population impact of multi-cohort HPV vaccination.
PMID 39528151 Published: 2024-11-10 Ingested: 2026-08-02 12:02 AM Preventive medicine
AI -
Standard 39.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 39.5/100. Study design: 25.0; human relevance: 35.0; therapeutic relevance: 20.0; sample size: 20.0; recency: 90.0; abstract quality: 100.0.

D
Racial and Demographic Disparities in Susceptibility to Health Misinformation on Social Media: National Survey-Based Analysis.
PMID 39504121 Published: 2024-11-06 Ingested: 2026-08-02 12:02 AM Journal of medical Internet research
AI -
Standard 39.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 39.5/100. Study design: 25.0; human relevance: 35.0; therapeutic relevance: 20.0; sample size: 20.0; recency: 90.0; abstract quality: 100.0.

D
Long-term trends in the burden of nasopharyngeal carcinoma in China: A comprehensive analysis from 1990 to 2021 and projections to 2030 based on the global burden of disease study 2021.
PMID 39489428 Published: 2024-11-01 Ingested: 2026-08-02 12:02 AM Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
AI -
Standard 39.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 39.5/100. Study design: 25.0; human relevance: 35.0; therapeutic relevance: 20.0; sample size: 20.0; recency: 90.0; abstract quality: 100.0.

D
Decisional conflict and knowledge in women with BRCA1/2 pathogenic variants: An exploratory age group analysis of a randomised controlled decision aid trial.
PMID 39446752 Published: 2024-10-24 Ingested: 2026-08-02 12:02 AM PloS one
AI -
Standard 39.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 39.5/100. Study design: 25.0; human relevance: 35.0; therapeutic relevance: 20.0; sample size: 20.0; recency: 90.0; abstract quality: 100.0.

D
Population-Level Distribution, Risk Factors, and Burden of Mortality and Disability-Adjusted Life Years Attributable to Major Noncommunicable Diseases in Western Europe (1990-2021): Ecological Analysis.
PMID 39418779 Published: 2024-10-17 Ingested: 2026-08-02 12:02 AM JMIR public health and surveillance
AI -
Standard 39.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 39.5/100. Study design: 25.0; human relevance: 35.0; therapeutic relevance: 20.0; sample size: 20.0; recency: 90.0; abstract quality: 100.0.

D
Exploring Prostate Cancer Incidence Trends and Age Change in Cancer Registration Areas of Jiangsu Province, China, 2009 to 2019.
PMID 39330036 Published: 2024-09-14 Ingested: 2026-08-02 12:02 AM Current oncology (Toronto, Ont.)
AI -
Standard 39.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 39.5/100. Study design: 25.0; human relevance: 35.0; therapeutic relevance: 20.0; sample size: 20.0; recency: 90.0; abstract quality: 100.0.

D
Global, regional, and national burden and trends of air pollution-related neoplasms from 1990 to 2019: An observational trend study from the Global Burden of Disease Study 2019.
PMID 39321528 Published: 2024-09-24 Ingested: 2026-08-02 12:02 AM Ecotoxicology and environmental safety
AI -
Standard 39.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 39.5/100. Study design: 25.0; human relevance: 35.0; therapeutic relevance: 20.0; sample size: 20.0; recency: 90.0; abstract quality: 100.0.

D
Age-period-cohort analysis of global, regional, and national pancreatic cancer incidence, mortality, and disability-adjusted life years, 1990-2019.
PMID 39198814 Published: 2024-08-28 Ingested: 2026-08-02 12:02 AM BMC cancer
AI -
Standard 39.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 39.5/100. Study design: 25.0; human relevance: 35.0; therapeutic relevance: 20.0; sample size: 20.0; recency: 90.0; abstract quality: 100.0.

D
Global burden of thyroid cancer from 1990 to 2021: a systematic analysis from the Global Burden of Disease Study 2021.
PMID 39192360 Published: 2024-08-27 Ingested: 2026-08-02 12:02 AM Journal of hematology & oncology
AI -
Standard 39.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 39.5/100. Study design: 25.0; human relevance: 35.0; therapeutic relevance: 20.0; sample size: 20.0; recency: 90.0; abstract quality: 100.0.

Previous
Page 3243 of 3363
Next
Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.
Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic